PhenomeX to Participate in American Association of Cancer Research Annual Meeting 2023

On April 7, 2023 PhenomeX Inc, the functional cell biology company, reported its participation at the American Association of Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting 2023 being held from April 14-19 at the Orange County Convention Center in Orlando, Fla (Press release, PhenomeX, APR 7, 2023, View Source [SID1234629892]). AACR (Free AACR Whitepaper) brings together scientists, clinicians, other health care professionals, survivors, patients, and advocates to share the latest advances in cancer science and Medicine."

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

At the conference, PhenomeX, the new company recently formed through the combination of Isoplexis and Berkeley Lights, will showcase its IsoSpark and Beacon optofluidic platform technologies and workflows in booth #3444. Attendees will have a chance to explore demonstrations of the technologies and learn more about how PhenomeX’s applications can provide unparalleled insights into cell function along the continuum of scientific discovery, bioprocessing, translational, and clinical research.

In addition, the AACR (Free AACR Whitepaper) Annual Meeting covers the latest advances in cancer through a variety of poster and speaker presentations. This year, PhenomeX technologies are highlighted in nine poster presentations ranging from Polyfunctional Profiles and Cytokine Secretion Activity of Transgenic TCR-T cells and Anti-Cancer Macrophage-Based Cell Therapy to the Identification of Myeloma-Specific T Cell Receptors by Functional Single Cell Interaction Analyses. Some of the presenting abstracts include:

Dr. Scott Nowicki (UCLA) Abstract | Section 37 / 914/29
Dr. Alejandro Villagra (Georgetown) Abstract | Section 37 – 900/15
Dr. Wafik El-Deiry (Brown) Abstract | Section 6 – 2518/26
Dr. Alejandro Villagra (Georgetown) Abstract | Section 21 – 2880/18
UT MD Anderson Abstract | Section 22 | 2903/8
University of Wisconsin, Madison Abstract | Section 25 – 4142/4
National Institutions of Health (NIH) Abstract | Section 23 – 4103/22